Medical News

RSS

Most of world's poorest still live in rural areas, despite progress over last decade, U.N. report says

A report from the U.N.'s International Fund for Agricultural Development found that approximately 350 million people living in rural areas have escaped extreme poverty over the past decade, but most of the world's poorest citizens continue to live in rural regions, the BBC reports (Melik, 12/6).

8 Dec 2010

New website provides guidelines to optimal stroke care

The 2010 Canadian Best Practice Recommendations for Stroke Care emphasize the need to prevent stroke patients from falling through the cracks as they move from the ER to in-hospital care to rehabilitation therapy and back to the community. The recommendations were released today by the Canadian Stroke Network and the Heart and Stroke Foundation of Canada.

8 Dec 2010

Employers pay more for health insurance, number of uninsured rises

PBS NewsHour: "The price businesses pay for their workers' health insurance has ballooned more than 41 percent over the past six years, according to a new study by the Commonwealth Fund. At the same time, many workers are getting less for the money -- per-person deductibles have risen 71 percent over those same years, according to the report.

8 Dec 2010

Research to improve prognosis for patients with dementia and Alzheimer's disease

Research on preventing the devastating onset of dementia is about to break new ground as McGill University, in partnership with Pfizer Canada, has announced today the creation of a professorship for the prevention of dementia and Alzheimer's-related diseases.

8 Dec 2010

FDA advisory committee's approval of Contrave for obesity encourages OAC, TOS, ASMBS

The Obesity Action Coalition, The Obesity Society and the American Society for Metabolic and Bariatric Surgery found encouragement in the outcome of today's advisory committee hearing, favoring approval for the first new obesity treatment in more than 10 years.

8 Dec 2010

Beike exits stem cell joint venture with SiriCell

Shenzhen Beike Biotechnology Co. Ltd. ("Beike") and SiriCell Technologies, Inc. announced that they are ending their partnership in "Beike Holdings Limited", a joint venture formed by the two companies in 2008. Going forward, Beike will exit the joint venture, and all current and future Beike Holdings-initiated business activities will operate exclusively under the SiriCell brand. Beike Holdings was established to expand the availability of Beike's stem cell products outside of China through collaborative hospital partnerships and new international subsidiaries.

8 Dec 2010

Case Western Reserve School of Medicine researchers receive NIH grant for four research endeavors

Case Western Reserve University School of Medicine faculty members are reaping the rewards of funding from the National Institutes of Health, in the form of grants and contracts. The funding totals more than $6.4 million for four different research endeavors.

8 Dec 2010

Reduced salt intake prevents serious threats in diabetic patients

For patients living with diabetes, reducing the amount of salt in their daily diet is key to warding off serious threats to their health, a new review of studies finds.

8 Dec 2010

Scientists work together to wipe out some of the most lethal diseases

Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.

8 Dec 2010

Immunomedics reports CD22 antibody produced significant anti-tumor response

Immunomedics, a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that epratuzumab, the Company's humanized anti-CD22 antibody, conjugated with SN-38, the active component of irinotecan, produced significant anti-tumor responses in a mouse model of human lymphoma.

8 Dec 2010

New Health Affairs study reexamines cost issues related to care in McAllen and El Paso

"Did McAllen get a bum rap? McAllen, Texas, spends more on Medicare patients than almost any other part of the country. A June 2009 New Yorker article by Atul Gawande attributed the high spending to a culture of doctors that 'came to treat patients the way sub-prime mortgage lenders treated home buyers: as profit centers.' The article became required reading in the White House and Congress during the health care debate and turned McAllen into shorthand for America's decadent medical spending problem."

8 Dec 2010

Issues in health delivery: Hospital-spread infections; Finger-prick blood tests for diabetes; Medicare spent millions on unnecessary stents

News outlets report on a variety of issues and developments related to quality of care and health delivery systems.

8 Dec 2010

Jackson Health System selects MedAssets as its strategic partner

MedAssets, Inc. announced today that Jackson Health System has selected the Company as its strategic partner to implement MedAssets' transformational approach to significantly lower supply costs, drive operational efficiencies and engage physicians in the cost and clinical utilization management improvement process.

8 Dec 2010

New technique may help develop novel treatments for brain diseases

Scientists have created a way to isolate neural stem cells - cells that give rise to all the cell types of the brain - from human brain tissue with unprecedented precision, an important step toward developing new treatments for conditions of the nervous system, like Parkinson's and Huntington's diseases and spinal cord injury.

8 Dec 2010

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.

8 Dec 2010

Children's Hospital LA investigators elected into the Society for Pediatric Research

Three investigators from The Saban Research Institute of Children's Hospital Los Angeles have been elected into the prestigious Society for Pediatric Research. Their election to this Society represents peer recognition of their research achievements in pediatrics.

8 Dec 2010

GlycoMimetics highlights clinical, preclinical progress of GMI-1070 in sickle cell crisis at ASH 2010

GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.

8 Dec 2010

Microsurgical technique effective in removing acoustic tumors

Surgery to remove tumors under the brain known as acoustic neuromas produces favorable outcomes in the "vast majority" of patients, according to one of the largest studies of its kind.

8 Dec 2010

HHS reaches out to defiant states for health law support

Health and Human Services Secretary Kathleen Sebelius is personally contacting incoming governors — many of whom are Republicans who campaigned against the health law — to try to build relationships that could prove critical to the law's implementation.

8 Dec 2010

Cephalon, Mesoblast to develop, commercialize novel adult MPC therapeutics

Cephalon, Inc. and Mesoblast Limited, today announced they have entered into a strategic alliance to develop and commercialize novel adult Mesenchymal Precursor Stem Cell therapeutics for degenerative conditions of the cardiovascular and central nervous systems.

8 Dec 2010

Medical News

Most of world's poorest still live in rural areas, despite progress over last decade, U.N. report says

New website provides guidelines to optimal stroke care

Employers pay more for health insurance, number of uninsured rises

Research to improve prognosis for patients with dementia and Alzheimer's disease

FDA advisory committee's approval of Contrave for obesity encourages OAC, TOS, ASMBS

Beike exits stem cell joint venture with SiriCell

Case Western Reserve School of Medicine researchers receive NIH grant for four research endeavors

Reduced salt intake prevents serious threats in diabetic patients

Scientists work together to wipe out some of the most lethal diseases

Immunomedics reports CD22 antibody produced significant anti-tumor response

New Health Affairs study reexamines cost issues related to care in McAllen and El Paso

Issues in health delivery: Hospital-spread infections; Finger-prick blood tests for diabetes; Medicare spent millions on unnecessary stents

Jackson Health System selects MedAssets as its strategic partner

New technique may help develop novel treatments for brain diseases

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Children's Hospital LA investigators elected into the Society for Pediatric Research

GlycoMimetics highlights clinical, preclinical progress of GMI-1070 in sickle cell crisis at ASH 2010

Microsurgical technique effective in removing acoustic tumors

HHS reaches out to defiant states for health law support

Cephalon, Mesoblast to develop, commercialize novel adult MPC therapeutics

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News